Legal claims defining the scope of protection, as filed with the USPTO.
3. The method of claim 1, wherein the user-specific configuration data comprises at least one of a group including information indicative of insulin-on-board, a safe basal rate, one or more insulin delivery rate limits, one or more glucose sensor calibration factors, an insulin sensitivity factor, and a history of insulin delivery.
4. The method of claim 1, wherein the first medical device comprises the first portion and the second portion, and wherein determining that the first medical device is being placed into service comprises determining that the first portion is removably attached to the second portion.
5. The method of claim 1, wherein determining that the first medical device is being placed into service comprises determining activation of the cannula insertion mechanism associated with the first medical device.
6. The method of claim 1, wherein determining that the first medical device is being placed into service comprises processing a signal from the skin contact sensor associated with the first medical device.
7. The method of claim 1, wherein determining that the first medical device is being placed into service comprises determining actuation of the mechanical switch between the first medical device and the patient.
8. The method of claim 1, wherein determining that the first medical device is being placed into service comprises determining that the glucose sensor is in contact with interstitial fluid.
9. The method of claim 1, wherein obtaining the user-specific configuration data comprises obtaining the user-specific configuration data through an intermediate device that obtains the user-specific configuration data from the second medical device.
10. The method of claim 1, wherein the data indicative of the first medical device being placed into service comprises a request for the user-specific configuration data.
12. The system of claim 11, wherein the user-specific configuration data comprises at least one of a group including information indicative of insulin-on-board, a safe basal rate, one or more insulin delivery rate limits, one or more glucose sensor calibration factors, an insulin sensitivity factor, and a history of insulin delivery.
13. The system of claim 11, wherein the first medical device comprises the first portion and the second portion, and wherein determining that the first medical device is being placed into service comprises determining that the first portion is removably attached to the second portion.
14. The system of claim 11, wherein determining that the first medical device is being placed into service comprises determining activation of the cannula insertion mechanism associated with the first medical device.
15. The system of claim 11, wherein determining that the first medical device is being placed into service comprises processing a signal from the skin contact sensor associated with the first medical device.
16. The system of claim 11, wherein determining that the first medical device is being placed into service comprises determining actuation of the mechanical switch between the first medical device and the patient.
17. The system of claim 11, wherein determining that the first medical device is being placed into service comprises determining that the glucose sensor is in contact with interstitial fluid.
18. The system of claim 11, wherein obtaining the user-specific configuration data comprises obtaining the user-specific configuration data through an intermediate device that obtains the user-specific configuration data from the second medical device.
19. The system of claim 11, wherein the data indicative of the first medical device being placed into service comprises a request for the user-specific configuration data.
Unknown
August 22, 2023
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.